“Revision Ventriculo-peritoneal shunts in children: Clinical profile and outcomes
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2023 - 65535
Project Lead
Authors
Dr.Shubha AM, Dr.Rajkiran Raju S, Dr.Aaron Vincent Lyngdoh(MBBS) and Dr.Steevan Sebastian(MBBS)-
Project Status
ongoing